Hutchin Hill Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-54,900
Closed -$470K – 988
2016
Q4
$470K Buy
+54,900
New +$470K 0.02% 597

Other funds holding NEO

Hutchin Hill Capital's NEO Position: Q1 2017 in Review

Hutchin Hill Capital sold out of NeoGenomics (NEO) in Q1 2017, closing a stake of 54,900 shares — an estimated $470K sold.

Hutchin Hill Capital first reported a position in NEO in Q4 2016 and held it in 1 quarter. The position peaked at $470K in Q4 2016. 143 funds tracked by Wall St. Rank hold NEO as of Q1 2017.

  • Hutchin Hill Capital reported no remaining NeoGenomics position as of Q1 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 54,900 NeoGenomics shares in Q1 2017, an estimated $470K.
  • Hutchin Hill Capital first reported a position in NeoGenomics in Q4 2016 and held it in 1 quarter.
  • Hutchin Hill Capital's NeoGenomics position peaked at $470K in Q4 2016.
  • 143 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.